Approval · Notice of Compliance 33055 · 2024
THYROGEN: Notice of Compliance 33055
Issued April 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33055
- Date
- April 11, 2024
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative / Administrative Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYROGEN | 02246016 | Marketed |
Medicinal ingredients
- THYROTROPIN ALFA 0.9 MG per VIAL